Royal Bank of Canada’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$236K Sell
259,948
-268,708
-51% -$244K ﹤0.01% 4703
2025
Q1
$237K Buy
528,656
+497,168
+1,579% +$223K ﹤0.01% 4232
2024
Q4
$16K Buy
31,488
+9,796
+45% +$4.98K ﹤0.01% 5708
2024
Q3
$20K Sell
21,692
-625,771
-97% -$577K ﹤0.01% 5641
2024
Q2
$646K Buy
647,463
+644,396
+21,011% +$643K ﹤0.01% 3452
2024
Q1
$4K Sell
3,067
-170,850
-98% -$223K ﹤0.01% 6056
2023
Q4
$189K Buy
173,917
+157,315
+948% +$171K ﹤0.01% 4630
2023
Q3
$19K Buy
16,602
+2,368
+17% +$2.71K ﹤0.01% 5705
2023
Q2
$20K Buy
14,234
+13,058
+1,110% +$18.3K ﹤0.01% 5754
2023
Q1
$2K Buy
1,176
+843
+253% +$1.43K ﹤0.01% 6388
2022
Q4
$0 Sell
333
-2,721
-89% ﹤0.01% 6956
2022
Q3
$3K Sell
3,054
-2,150
-41% -$2.11K ﹤0.01% 6407
2022
Q2
$8K Sell
5,204
-3,272
-39% -$5.03K ﹤0.01% 6003
2022
Q1
$13K Sell
8,476
-20,487
-71% -$31.4K ﹤0.01% 6347
2021
Q4
$71K Buy
28,963
+12,670
+78% +$31.1K ﹤0.01% 5638
2021
Q3
$41K Buy
16,293
+7,205
+79% +$18.1K ﹤0.01% 5754
2021
Q2
$26K Buy
9,088
+4,475
+97% +$12.8K ﹤0.01% 5923
2021
Q1
$11K Sell
4,613
-3,229
-41% -$7.7K ﹤0.01% 6264
2020
Q4
$13K Sell
7,842
-195
-2% -$323 ﹤0.01% 5710
2020
Q3
$8K Sell
8,037
-3,301
-29% -$3.29K ﹤0.01% 5509
2020
Q2
$10K Buy
11,338
+8,262
+269% +$7.29K ﹤0.01% 5354
2020
Q1
$3K Sell
3,076
-6,667
-68% -$6.5K ﹤0.01% 5687
2019
Q4
$9K Buy
9,743
+1,745
+22% +$1.61K ﹤0.01% 5586
2019
Q3
$8K Buy
7,998
+3,000
+60% +$3K ﹤0.01% 5218
2019
Q2
$6K Buy
4,998
+341
+7% +$409 ﹤0.01% 5340
2019
Q1
$6K Buy
4,657
+57
+1% +$73 ﹤0.01% 5267
2018
Q4
$4K Sell
4,600
-745
-14% -$648 ﹤0.01% 5367
2018
Q3
$11K Sell
5,345
-2,314
-30% -$4.76K ﹤0.01% 5334
2018
Q2
$14K Buy
7,659
+4,655
+155% +$8.51K ﹤0.01% 5123
2018
Q1
$7K Buy
3,004
+2,749
+1,078% +$6.41K ﹤0.01% 5225
2017
Q4
$0 Sell
255
-10,644
-98% ﹤0.01% 5907
2017
Q3
$27K Buy
10,899
+6,975
+178% +$17.3K ﹤0.01% 5047
2017
Q2
$11K Sell
3,924
-3,762
-49% -$10.5K ﹤0.01% 5020
2017
Q1
$23K Sell
7,686
-1,772
-19% -$5.3K ﹤0.01% 4878
2016
Q4
$30K Buy
9,458
+4,640
+96% +$14.7K ﹤0.01% 4789
2016
Q3
$17K Sell
4,818
-11,547
-71% -$40.7K ﹤0.01% 4841
2016
Q2
$37K Buy
16,365
+9,392
+135% +$21.2K ﹤0.01% 4548
2016
Q1
$18K Sell
6,973
-1,332
-16% -$3.44K ﹤0.01% 4834
2015
Q4
$28K Buy
8,305
+530
+7% +$1.79K ﹤0.01% 4827
2015
Q3
$19K Sell
7,775
-741
-9% -$1.81K ﹤0.01% 4993
2015
Q2
$25K Buy
8,516
+5,146
+153% +$15.1K ﹤0.01% 5094
2015
Q1
$13K Buy
3,370
+290
+9% +$1.12K ﹤0.01% 5039
2014
Q4
$9K Hold
3,080
﹤0.01% 5056
2014
Q3
$8K Sell
3,080
-929
-23% -$2.41K ﹤0.01% 4986
2014
Q2
$10K Hold
4,009
﹤0.01% 4893
2014
Q1
$10K Buy
4,009
+850
+27% +$2.12K ﹤0.01% 4880
2013
Q4
$10K Sell
3,159
-206
-6% -$652 ﹤0.01% 4818
2013
Q3
$11K Buy
3,365
+206
+7% +$673 ﹤0.01% 4804
2013
Q2
$10K Buy
+3,159
New +$10K ﹤0.01% 4676